Papers
4
Total Citations
65
H-Index
3
About
Dr. Joris Giai is a pioneering surgeon whose research sits at the intersection of urologic oncology and advanced robotic technology. His work is defined by a rigorous, evidence-based approach to challenging surgical questions, particularly concerning the trade-offs between oncologic control and functional preservation. Dr. Giai is best known for leading the landmark EMERALD trial, a randomized controlled study that demonstrated superselective ischemia during robotic partial nephrectomy does not improve long-term renal function compared to standard renal artery clamping—a finding with over 30 citations that directly challenges a widely-held surgical assumption. He has also made significant contributions to prostate cancer management, notably investigating the feasibility of radical prostatectomy following vascular-targeted photodynamic therapy with padeliporfin, a novel treatment pathway. His current work continues to push boundaries, as evidenced by the ACCURATE protocol for 3D-image-guided robotic nephrectomy and a randomized trial comparing robotic arm-assisted to conventional total knee arthroplasty. Through these high-impact studies, Dr. Giai demonstrates a commitment to generating the high-quality evidence needed to refine surgical practice and improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4